NLS Pharmaceutics Ltd - Warrants (25/09/2025) Other Current Liabilities

As of the most recent data (June 2025), NLSPW shows a other current liabilities of $430K. That compares with $280K in the prior-year period — up 56.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NLSPW's other current liabilities is now $430K (was $280K) — a 56.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NLS Pharmaceutics Ltd - Warrants (25/09/2025) is outperforming or lagging.

Tracking NLSPW's other current liabilities over time shows whether NLS Pharmaceutics Ltd - Warrants (25/09/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $430K That compares with $280K in the prior-year period — up 56.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $430K) with ownership activity and broader fundamentals.

NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s other current liabilities is $430K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.